Lyell Immunopharma Inc Net Asset Quality Index
Lyell Immunopharma Inc net asset quality index. Lyell Immunopharma Inc (LYEL) has a Net Asset Quality Index of 75.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $311.15 Million minus total liabilities of $77.34 Million yields net assets of $233.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Lyell Immunopharma Inc for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Lyell Immunopharma Inc (2019–2025)
Net asset quality index of Lyell Immunopharma Inc from 2019 to 2025. This chart shows how Lyell Immunopharma Inc's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the index stands at 75.1%, representing net assets of $233.81 Million against total assets of $311.15 Million USD. Check how strategically is Lyell Immunopharma Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Lyell Immunopharma Inc Net Asset Quality Index by Year (2019–2025)
Lyell Immunopharma Inc net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for Lyell Immunopharma Inc from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Lyell Immunopharma Inc (LYEL) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 73.0% | $248.20 Million | $340.05 Million | $91.85 Million | ▼ -5.0 pp |
| 2024 | 78.0% | $382.82 Million | $490.86 Million | $108.03 Million | ▼ -9.3 pp |
| 2023 | 87.3% | $654.95 Million | $750.03 Million | $95.08 Million | ▼ -1.6 pp |
| 2022 | 88.9% | $833.25 Million | $937.56 Million | $104.31 Million | ▲ +6.4 pp |
| 2021 | 82.5% | $929.79 Million | $1.13 Billion | $197.62 Million | ▲ +3.4 pp |
| 2020 | 79.1% | $718.44 Million | $908.28 Million | $189.84 Million | ▲ +5.7 pp |
| 2019 | 73.4% | $408.06 Million | $555.63 Million | $147.58 Million | — |